Introduction The COVID pandemic prompted a significant increase in the utilization of
telemedicine (TM) for substance use disorder (SUD) treatment. As we transition towards a …

Background Cannabis is increasingly consumed and increasingly perceived as harmless.
Among those whose use develops into a cannabis use disorder (CUD),< 5% initiate and …

Background There are limited data on whether modifiable social factors foster psychological
resilience and mental well-being among people who use drugs following Big Events. We …

Background Telehealth has the potential to improve health care access for patients but it has
been underused and understudied for examining patients with substance use disorders …

Background Substance use disorder treatment and recovery support services are critical for
achieving and maintaining recovery. There are limited data on how structural and social …

Introduction Rural primary care clinics can expand their medication treatment for opioid use
disorder (MOUD) capacity by coordinating care with external telemedicine (TM) vendors …

Background During the COVID-19 pandemic, federal regulations in the USA for methadone
treatment of opioid use disorder (OUD) were temporarily revised to reduce clinic crowding …

Introduction: Alcohol and other drug (AOD) treatment services were required to rapidly adapt
delivery of care in response to the coronavirus (COVID-19) pandemic. This study examined …

Objectives We examined substance use hotline operator certainty of each US state and
Washington, DC's endorsement of buprenorphine (initiation and continuation) prescribing …

Objective We evaluated the impact of a telemedicine bridge clinic on treatment outcomes
and cost for patients with opioid use disorder. Telemedicine bridge clinics deliver low-barrier …